Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Multiple Myeloma; Neoplasms, Plasma Cell | Phase 1 | ClinicalTrials |
| Kidney Diseases; Renal Insufficiency, Chronic | Phase 2 | ClinicalTrials |
| Kidney Diseases; Renal Insufficiency, Chronic | Phase 2 | ClinicalTrials |
| Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid | Phase 2 | ClinicalTrials |
| Lymphoma; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse | Phase 1/Phase 2 | ClinicalTrials |
| Kidney Diseases; Renal Insufficiency, Chronic | Phase 2 | ClinicalTrials |
| Kidney Diseases; Renal Insufficiency, Chronic | Phase 1 | ClinicalTrials |
| Kidney Diseases; Renal Insufficiency, Chronic | Phase 2 | ClinicalTrials |
CONTENTS